Why the study?
Does the combination of CRP and NT-proBNP accurately discriminate acute exacerbations of COPD requiring hospitalization from stable COPD?
Population
578 patients, comprising 468 hospitalized with a primary diagnosis of acute exacerbation of chronic…
Comparison
Measurement of serum C-reactive protein and… vs Stable COPD patients (clinical stability).
Design
Cohort
Authors
Loading...
The combination of CRP and NT-proBNP biomarkers can accurately discriminate acute exacerbations of COPD requiring hospitalization from stable disease.
Does the combination of CRP and NT-proBNP accurately discriminate acute exacerbations of COPD requiring hospitalization from stable COPD?
The combination of CRP and NT-proBNP biomarkers can accurately discriminate acute exacerbations of COPD requiring hospitalization from stable disease.
Chen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: